Stomach Neoplasms: all 2,914 studies
Page 5 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- Tislelizumab Combined with SOX and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Metastasis: a Prospective Cohort StudyNot yet recruitingNCT06682182
- Brodalumab in the Treatment of Immune-Related Adverse EventsRecruitingNCT06673329Phase 1
- Hypoxia Driven Metabolic Response in Oesophagogastric AdenocarcinomaRecruitingNCT06669663
- Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)RecruitingNCT06668454Not applicable
- SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal CancerNot yet recruitingNCT06666166Phase 2
- IMmune Proteomics to Predict NeoAdjuvant Chemotherapy and ImmunoTherapy Response in Gastric CancerRecruitingNCT06662110
- A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsRecruitingNCT06657144Phase 1
- Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and TreatmentRecruitingNCT06653478
- PET-imaging of Two Vartumabs in Patients With Solid TumorsRecruitingNCT06645808Early Phase 1
- Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.RecruitingNCT06642857
- Efficacy of RUS GA Surgical Navigation for Robot-assisted Distal Gastrectomy in Gastric Cancer PatientsRecruitingNCT06639490Not applicable
- Perioperative Therapies in Locally Advanced Unresectable Gastric CancerRecruitingNCT06630130Phase 2
- A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR PathwayNot yet recruitingNCT06614751Phase 1
- Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer (KLASS-10)RecruitingNCT06608381Phase 3
- The Efficacy and Safety of Benmelstobart for GC/EGCNot yet recruitingNCT06603974Not applicable
- ImmunoPET Imaging of Pancreatic CancerRecruitingNCT06602037Not applicable
- The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.RecruitingNCT06597526
- The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric CancerNot yet recruitingNCT06592287Phase 1/2
- Clinical Trial to Evaluate the Efficacy and Safety of a Thoracic and Abdominal Endoscopic Surgical SystemEnrolling by invitationNCT06587152Not applicable
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsRecruitingNCT06586957Phase 1
- Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon CancersRecruitingNCT06580574Phase 2
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Immunonutrition and Psychosocial Factors in the Recovery of Patients After Gastrectomy: a Multidimensional AnalysisNot yet recruitingNCT06578858
- A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver MetastasisNot yet recruitingNCT06564298Phase 2
- Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 OverexpressionRecruitingNCT06560528Phase 2
- A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric CancerRecruitingNCT06555471Phase 2
- HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological OutcomesRecruitingNCT06550063
- Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric CancerRecruitingNCT06543108
- Development and Application of an Artificial Intelligence-driven Accurate Identification Model for Gastric Cancer Lymph Node MetastasisRecruitingNCT06534814
- TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal CancerRecruitingNCT06532799Phase 1/2
- A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric CancerRecruitingNCT06532006Phase 3
- Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric CancerNot yet recruitingNCT06525714Early Phase 1
- Gastric Cancer Complicated With BleedingNot yet recruitingNCT06522542
- Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatment Prior to GastrectomyRecruitingNCT06521541Not applicable
- Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal MetastasisRecruitingNCT06519591Phase 2
- The Anti-reflux Effect of Double-flap Technique in Laparoscopic Proximal Gastrectomy.Not yet recruitingNCT06511609Not applicable
- A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid TumorsRecruitingNCT06508307Phase 1
- Construction and Application of Database of Hebei Provincial Gastric Cancer Collaborative Network Driven by Artificial Intelligence TechnologyRecruitingNCT06506825
- To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric CancerRecruitingNCT06504732Phase 2/3
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer DetectionRecruitingNCT06503146Phase 2
- A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid TumorsRecruitingNCT06500052Phase 1
- Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric CancerNot yet recruitingNCT06499610Phase 4
- A Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intraperitoneal Infusion of rmhTNF in Gastric and Colorectal Malignant TumorsNot yet recruitingNCT06496919
- Miss Rate of Gastric Neoplasms Under Computer-aided EndoscopyRecruitingNCT06495645Not applicable
- Prospective Observational Cohort StudyNot yet recruitingNCT06493448
- RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric CancerNot yet recruitingNCT06492317Phase 2
- Predicting Peripheral Neuropathy of Paclitaxel for Gastric CancerRecruitingNCT06490159
- Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal MetastasisEnrolling by invitationNCT06487715Phase 2
- Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric CancerRecruitingNCT06487429Phase 2
- Avutometinib and Defactinib in Diffuse Gastric CancerRecruitingNCT06487221Phase 2
- A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric CancerRecruitingNCT06485271
- Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric CancerRecruitingNCT06478394
- Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric CancerRecruitingNCT06475417Phase 2
- Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal GastrectomyRecruitingNCT06475170Not applicable
- Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC StudyRecruitingNCT06472063
- Enhanced vs. Routine Follow-Up After Total Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled TrialNot yet recruitingNCT06468969Not applicable
- Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric CancerRecruitingNCT06468280Phase 2
- Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)RecruitingNCT06466902
- Stapler Reinforcement Patches Compared to Standard Staplers in GastrojejunostomyRecruitingNCT06464978Not applicable
- A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric CancerNot yet recruitingNCT06464601
- Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT06461910Phase 2
- Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric CancerNot yet recruitingNCT06459921Phase 2
- Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric CancerNot yet recruitingNCT06454435Phase 2
- Predicting Gastric Cancer Response to Chemo With Multimodal AI ModelRecruitingNCT06451393
- Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric CancerRecruitingNCT06451211Phase 2
- Cancer Loyalty Card Study 2 (CLOCS-2)RecruitingNCT06447064
- Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJCNot yet recruitingNCT06439550Phase 2
- Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric CancerNot yet recruitingNCT06437678Phase 2
- Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.Not yet recruitingNCT06435741Not applicable
- The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric CancerRecruitingNCT06432205
- Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric CancerNot yet recruitingNCT06432075Early Phase 1
- Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target VisualizationRecruitingNCT06429891Not applicable
- Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric CancerNot yet recruitingNCT06426654Phase 1/2
- Personalised Health Recommendations to the General Population Through an Integrated AI GuidedRecruitingNCT06421324Not applicable
- Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric CancerNot yet recruitingNCT06421220Not applicable
- Myosteatosis in Oeso-gastric Cancer: Clinical ImpactsRecruitingNCT06419244Not applicable
- Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ AdenocarcinomaRecruitingNCT06417892
- Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer PatientsNot yet recruitingNCT06414122Not applicable
- Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach CancerRecruitingNCT06408220Not applicable
- FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric CancerRecruitingNCT06405113Phase 2
- Prediction Model of Occult Omental Metastasis in Patients With Gastric CancerRecruitingNCT06405009
- Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics IntegrationRecruitingNCT06396143
- Wecare Study in Gastric Cancer SurvivorsRecruitingNCT06395935Not applicable
- A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesRecruitingNCT06395519Phase 1/2
- Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)Enrolling by invitationNCT06391749
- Comparison of pCLE and EB in Gastric Lesion DiagnosisRecruitingNCT06389448Not applicable
- RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric CancerNot yet recruitingNCT06385873Phase 2
- Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.RecruitingNCT06385691Phase 2
- Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in ChinaNot yet recruitingNCT06384300Not applicable
- Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total GastrectomyRecruitingNCT06383793
- Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer PatientsRecruitingNCT06383559Phase 2
- A Phase I/II Trial of UCB4594 in Participants With Advanced CancerRecruitingNCT06380816Phase 1/2
- Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.Not yet recruitingNCT06374901Phase 2
- Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGCRecruitingNCT06371586Phase 2
- A Study Collecting Health Information to Understand and Prevent Gastric CancerRecruitingNCT06370143
- Sintilimab Plus FOLFIRI as Second-line Therapy for Patients With HER2-negative Advanced Gastric CancerNot yet recruitingNCT06365008Phase 2
- Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid TumorsRecruitingNCT06364410Phase 1
- Comparison of Outcomes of Multiple Platforms for Assisted Robotic - GastrectomyRecruitingNCT06362070Not applicable
- Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal GastrectomyRecruitingNCT06354036Not applicable
- Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric CancerNot yet recruitingNCT06349967Phase 2